Nkiruka Emeagwali is a Respiratory physician affiliated with Yale University. OpenAlex indexes 7 publications with 301 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
44 N Plains Industrial Road
Wallingford, CT 06492
Telephone
917-881-8298Provider last certified this registry record 9 Jan 2020.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202310 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
78.3%Corticosteroid42.9%Trelegy Ellipta39%Fluticasone Propionate15%Breo Ellipta15%Symbicort11%Arnuity Ellipta7%Dulera5%Breyna5%Budesonide-Formoterol Fumarate4%Part D<11 patientsbeta2-Adrenergic Agonist19%Albuterol Sulfate Hfa63%Ventolin Hfa37%Part D≥75 patients+ 4 more classes in this area
Metabolism & gastrointestinal
14.6%Corticosteroid8%Prednisone100%Part D≥56 patientsProton pump inhibitor5.4%Omeprazole100%Part D≥25 patients+ 1 more class in this area
Anti-infectives
4%Macrolide Antimicrobial3.3%Azithromycin100%Part D≥30 patientsFluoroquinolone Antibacterial0.7%Levofloxacin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis
European Respiratory Journal
2021 - New Applications of Old Drugs as Novel Therapies in Idiopathic Pulmonary Fibrosis: Metformin, Hydroxychloroquine, and Thyroid Hormone
American Journal of Respiratory and Critical Care Medicine
2019 - Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis
New England Journal of Medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”